Aikya Investment Management Ltd has submitted its latest 13F-HR filing, revealing a total value of approximately $67.5 million in its investment holdings as of September 30, 2026. This report is significant as it provides insight into the company's investment strategy and its positions in various securities.

The filing indicates that Aikya Investment Management, based in London, has made substantial investments in several notable companies. Among its largest holdings are HDFC Bank Limited, with a reported value of over $90 million, and Dr. Reddy's Laboratories Limited, valued at approximately $114 million. The report also includes stakes in Infosys Ltd, EPAM Systems Inc, and MakeMyTrip LTD.

Background

Aikya Investment Management Ltd is a financial services firm that specializes in investment management. The company is incorporated in London and is categorized as an "other" entity type according to SEC filings. Its recent filings include a series of 13F-HR reports, with the latest filed on November 6, 2026, under accession number 0002005403-26-000008.

What the Filing Says

The 13F-HR filing provides a summary of the company’s investment holdings as of the end of the third quarter of 2026. The report states, "The total value of the holdings is $67,489,259, with five entries in the report." This reflects Aikya's focused investment approach.

Impact

This filing may affect various stakeholders, including investors and analysts who track investment management firms. The reported holdings can influence investor sentiment and strategies, particularly in the sectors where Aikya has significant investments.

What's Next

The filing does not say what happens next.